Integrated Financial Statements From 2010 to 2024

Stocks UK . 
Stock . Integrated Diagnostics Holdings
IDHC Stock   0.45  0.02  4.65%   
Integrated Diagnostics financial statements provide useful quarterly and yearly information to potential Integrated Diagnostics Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Integrated Diagnostics financial statements helps investors assess Integrated Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Integrated Diagnostics' valuation are summarized below:
Gross Profit
2.8 B
Profit Margin
0.1721
Exchange Market
LSE - MAIN MARKET
Market Capitalization
26.2 B
Enterprise Value Revenue
2.6887
There are over eighty available fundamental trends for Integrated Diagnostics, which can be analyzed over time and compared to other ratios. All traders should confirm Integrated Diagnostics' regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Integrated Diagnostics Total Revenue

2.35 Billion

Check Integrated Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 421.3 M, Selling General Administrative of 168.1 M or Selling And Marketing Expenses of 92 M, as well as many indicators such as . Integrated financial statements analysis is a perfect complement when working with Integrated Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Integrated Diagnostics Technical models . Check out the analysis of Integrated Diagnostics Correlation against competitors.

Integrated Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.1 B5.8 B3.5 B
Slightly volatile
Short and Long Term Debt Total1.2 B1.2 B284.1 M
Slightly volatile
Total Current Liabilities880.3 M1.3 B730 M
Slightly volatile
Total Stockholder Equity2.4 B2.7 B2.2 B
Slightly volatile
Property Plant And Equipment Net2.2 B2.1 B859.2 M
Slightly volatile
Accounts Payable165.7 M271.7 M136.7 M
Slightly volatile
Cash572.3 M674.3 M498.8 M
Slightly volatile
Non Current Assets Total2.8 B3.8 B2.5 B
Slightly volatile
Cash And Short Term Investments815.7 M860.5 M692.1 M
Slightly volatile
Net Receivables600.1 M571.5 M226.7 M
Slightly volatile
Good Will1.4 B1.3 B1.3 B
Slightly volatile
Common Stock Total Equity917.7 M1.2 B787 M
Slightly volatile
Common Stock Shares Outstanding480 M540 M588 M
Slightly volatile
Liabilities And Stockholders Equity4.1 B5.8 B3.5 B
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B563.9 M
Slightly volatile
Inventory393.4 M374.6 M121.4 M
Slightly volatile
Other Current Assets163.5 M155.7 M75.7 M
Slightly volatile
Total Liabilities1.5 B2.7 B1.2 B
Slightly volatile
Property Plant And Equipment Gross3.4 B3.2 B1.1 B
Slightly volatile
Total Current Assets1.3 B2 B1.1 B
Slightly volatile
Intangible Assets335.8 M422.9 M436.7 M
Slightly volatile
Common Stock983.2 M1.2 B791.4 M
Slightly volatile
Other Liabilities222.5 M427 M216.1 M
Slightly volatile
Net Tangible Assets551.2 M1.1 B511.5 M
Slightly volatile
Short and Long Term Debt29.7 M43.7 M30 M
Pretty Stable
Property Plant Equipment1.8 B1.7 B780.9 M
Slightly volatile
Current Deferred Revenue150.6 M161.1 M184.5 M
Slightly volatile
Other Assets9.6 M6.1 M17.9 M
Slightly volatile
Short Term Investments365.1 M186.3 M239.6 M
Slightly volatile
Capital Lease Obligations556.7 M1.1 B367.8 M
Slightly volatile
Capital Surpluse822.2 M924.9 M1 B
Slightly volatile
Net Invested Capital2.7 B2.8 B2.4 B
Slightly volatile
Net Working Capital468.6 M686.9 M460.7 M
Pretty Stable
Capital Stock858 M965.2 M1.1 B
Slightly volatile

Integrated Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization421.3 M401.2 M173 M
Slightly volatile
Selling General Administrative168.1 M256.1 M151 M
Slightly volatile
Selling And Marketing Expenses92 M145.3 M76.2 M
Slightly volatile
Total Revenue2.3 B4.1 B2 B
Slightly volatile
Gross Profit1.1 B1.5 B898.5 M
Slightly volatile
Other Operating Expenses3.6 B3.4 B1.5 B
Slightly volatile
Operating Income765.5 M737.8 M616.5 M
Slightly volatile
EBIT776.5 M879 M625.2 M
Slightly volatile
EBITDA951.5 M1.3 B781.9 M
Slightly volatile
Cost Of Revenue2.7 B2.6 B1.2 B
Slightly volatile
Total Operating Expenses825.9 M786.6 M322.5 M
Slightly volatile
Income Before Tax729.5 M737.4 M591 M
Slightly volatile
Net Income464.7 M510.3 M372.3 M
Slightly volatile
Income Tax Expense258.1 M269 M212.8 M
Slightly volatile
Interest Expense148.8 M141.7 M45.3 M
Slightly volatile
Net Income From Continuing Ops511.4 M468.4 M388.8 M
Slightly volatile
Net Income Applicable To Common Shares1.7 B1.6 B594.9 M
Slightly volatile
Tax Provision339.1 M269 M235.6 M
Slightly volatile
Interest Income70.1 M72.8 M47.2 M
Slightly volatile
Reconciled Depreciation225.6 M401.2 M139.6 M
Slightly volatile

Integrated Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation421.3 M401.2 M173 M
Slightly volatile
Capital Expenditures179.8 M325.9 M146.2 M
Slightly volatile
Total Cash From Operating Activities669.2 M543.7 M616.5 M
Pretty Stable
Net Income723.7 M737.4 M577.9 M
Slightly volatile
End Period Cash Flow596 M674.3 M552.5 M
Slightly volatile
Begin Period Cash Flow556.5 M648.5 M474.5 M
Slightly volatile
Change To Netincome604 M575.2 M191.6 M
Slightly volatile

Integrated Fundamental Market Drivers

Forward Price Earnings12.8866
Cash And Short Term Investments860.5 M

About Integrated Diagnostics Financial Statements

Integrated Diagnostics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Integrated Diagnostics investors may analyze each financial statement separately, they are all interrelated. The changes in Integrated Diagnostics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integrated Diagnostics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue161.1 M150.6 M
Total Revenue4.1 B2.3 B
Cost Of Revenue2.6 B2.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY